Stifel Maintains Matson(MATX.US) With Hold Rating, Cuts Target Price to $130
Stephens Maintains Matson(MATX.US) With Buy Rating, Cuts Target Price to $150
Matson Is Maintained at Hold by Stifel
Stephens & Co. Maintains Overweight on Matson, Lowers Price Target to $150
Matson Analyst Ratings
Jefferies Initiates Coverage On Matson With Buy Rating, Announces Price Target of $125
Jefferies Initiates Matson(MATX.US) With Buy Rating, Announces Target Price $125
Analysts Offer Insights on Industrial Goods Companies: Matson (MATX), Builders Firstsource (BLDR) and Controladora Vuela Compania De Aviacion SAB De CV (VLRS)
Matson Is Maintained at Hold by Stifel
Matson Analyst Ratings
Stifel Maintains Matson(MATX.US) With Hold Rating, Raises Target Price to $160
Stephens Maintains Matson(MATX.US) With Buy Rating, Raises Target Price to $175
Artivion Receives Buy Rating From Michael Matson Following Promising Clinical Trial Results and Market Expansion Opportunities
Stifel Maintains Matson(MATX.US) With Hold Rating, Raises Target Price to $150
Matson Analyst Ratings
Stephens & Co. Reiterates Overweight on Matson, Maintains $165 Price Target
Matson Analyst Ratings
Stifel Maintains Matson(MATX.US) With Hold Rating, Maintains Target Price $136
Penumbra's Thunderbolt Study Progress and Market Impact: Matson Maintains Hold Rating
Hologic's Strategic Acquisition of Gynesonics Bolsters Market Position: A Buy Rating by Michael Matson